Ketamine’s promise as an antidepressant is being undermined by its lack of profit

Ketamine’s promise as an antidepressant is being undermined by its lack of profit

The FDA approved a drug, esketamine, that can help with depression. But some psychiatrists question why ketamine, its cheaper cousin, isn't being similarly developed.